What “potency” means in cannabis
Then: lower average THC, more balanced cannabinoid profiles\
Historical cannabis often had lower average THC than many modern products. Exact historical averages vary depending on region, storage, testing methods, and what was being sampled, but the broader pattern across decades is consistent: earlier markets generally had lower THC and often relatively more CBD than today’s high-THC chemotypes.
Now: higher THC averages and a wider gap between THC and CBD
Large analyses of samples show that average THC levels in U.S. cannabis rose steadily from the mid-1990s onward. A landmark paper analyzing tens of thousands of samples reported an increase in average THC in cannabis plant material from about 4% (1995) to about 12% (2014), alongside a decline in CBD and a rising THC:CBD ratio.
More recent U.S. testing across 2009–2019 also found increases over that period, with mean THC rising into the mid-teens in several years. And this is not only a U.S. story. The EU drug monitoring agency (EUDA) reports that in Europe, cannabis resin (hash) potency has climbed notably.
Why potency increased: cultivation, selection, and concentrates
Several forces pushed potency upward, gradually reshaping cannabis over time and setting the stage for the much stronger products common today.
Growers increasingly selected genetics and methods that maximized THC production, reflecting a gradual shift in how cannabis was cultivated and evaluated. Over time, emphasis moved toward potency, influencing which plants were bred, how they were grown, and what ultimately reached consumers. This long-term focus helped drive higher average THC levels across many products available today.
Higher-THC products have often commanded higher prices and stronger consumer interest, particularly in competitive legal markets where potency is highly visible on labels. As a result, THC percentage has become an important signal of value for many consumers. Research suggests this emphasis can shape how products are marketed and perceived, with some studies finding that labeled THC levels may be overstated to better align with customer expectations.
Why the “then vs now” shift matters for health
Higher THC exposure can raise the likelihood of adverse effects, especially for inexperienced users, people who use frequently, or those with mental health vulnerabilities. Major health agencies note risks related to brain function, impairment, and cannabis use disorder.
Bottom line
Cannabis potency has increased substantially over the past few decades, and today’s markets also include product types that can deliver much more THC than traditional flower. The most consistent takeaway from the research is simple and empowering: dose matters more than ever. As THC concentrations rise, using the same amount one might have used in the past can lead to a very different experience, making it especially important to adjust slowly and find what feels right.
